Highlights:
Treatment options for Small-cell lung cancer (SCLC) can be identified using a blood test based on a research study from The University of Manchester.
The research findings was published in the journal Nature Medicine- Lung cancer is the second most common cancer in men and women.
- Blood test found to identify treatment options for lung cancer.
- Identifying the genetic differences will help to find the best treatment for lung cancer.
Lung Cancer - Types, Causes, Symptoms, Diagnosis, Treatment and Prevention
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with symptoms like recurrent respiratory diseases.
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with symptoms like recurrent respiratory diseases.
‘Blood samples can be used to predict the best treatment options for lung cancer.’
Tweet it Now
Lung cancer is often characterized by abnormal cell growth in the lungs. It is the second most common cancer in men and women.Lung cancer mainly occurs in older people who are above the age of 65.
Scientists isolated circulating tumor cells (CTCs) from the blood of 31 lung cancer patients.. These cells were found to be located away from the main cancer.
Osimertinib for Lung Cancer Available Through NHS
The availability of the anti-cancer drug osimertinib through the NHS will make it more accessible to EGFR T790M-positive lung cancer patients in the UK.
The availability of the anti-cancer drug osimertinib through the NHS will make it more accessible to EGFR T790M-positive lung cancer patients in the UK.
Lung biopsy which involves the analysis of tumor sample from lung cancer patients can often be difficult as it is hard to reach the tissue and also the samples obtained are too small to reveal clue for identifying the treatment options for the disease.
Advertisement
Quiz on Lung Cancer
Lung cancer and smoking are closely associated. Lung cancer risk increases with the intensity of smoking. For more details, take this quiz.
Lung cancer and smoking are closely associated. Lung cancer risk increases with the intensity of smoking. For more details, take this quiz.
The research team explored the genetic changes associated in patients who responded well to the treatment initially and later deteriorate. These patterns were different from those patients who did not respond properly to chemotherapy.
Advertisement
Lung Cancer
Do you want to get instant visual information on Lung Cancer. Use this infographics on Lung Cancer to get all the important information on this cancer that is responsible for 1.59 million deaths every year.
Do you want to get instant visual information on Lung Cancer. Use this infographics on Lung Cancer to get all the important information on this cancer that is responsible for 1.59 million deaths every year.
"Unfortunately, we have very few treatment options for patients with SCLC, and none at all for those whose cancer is resistant to chemotherapy.”
"By identifying differences in the patterns of genetic faults between patients, we now have a starting point to begin to understand more about how drug resistance develops in patients with this aggressive form of lung cancer."
Dr Emma Smith, Cancer Research UK's science information manager also said that, "Lung cancer causes more than one in five of all cancer deaths in the UK and it's vital that we find effective new treatments to fight the disease and save more lives.
"These liquid biopsies are an incredibly exciting area of research. Studies like this help build a bigger picture of the disease, pointing the way to developing new treatments that are urgently needed for people with lung cancer."
Source-Medindia
